Managing Perioperative Pain After Anterior Cruciate Ligament (ACL) Reconstruction: Perspectives from a Sports Medicine Surgeon
Ioanna K Bolia,Aryan Haratian,Jennifer A Bell,Laith K Hasan,Nima Saboori,Ryan Palmer,Frank A Petrigliano,Alexander E Weber
DOI: https://doi.org/10.2147/OAJSM.S266227
2022-01-20
Open Access Journal of Sports Medicine
Abstract:Ioanna K Bolia, Aryan Haratian, Jennifer A Bell, Laith K Hasan, Nima Saboori, Ryan Palmer, Frank A Petrigliano, Alexander E Weber USC Epstein Family Center for Sports Medicine at Keck Medicine of USC, Los Angeles, CA, USA Correspondence: Alexander E Weber USC Epstein Family Center for Sports Medicine at Keck Medicine of USC, 1520 San Pablo Street, Suite 2000, Los Angeles, CA, 90033, USA Email Anterior cruciate ligament reconstructions (ACLR) are a relatively common procedure in orthopedic sports medicine with an estimated 130,000 arthroscopic operations performed annually. Most procedures are carried out on an outpatient basis, and though success rates of ACLR are as high as 95%, pain remains the most common postoperative complication delaying patient discharge, and thereby increasing the costs associated with patient care. Despite the success and relative frequency of ACLR surgery, optimal and widely accepted strategies and regimens for controlling perioperative pain are not well established. In recent years, the paradigm of pain control has shifted from exclusively utilizing opiates and opioid medications in the acute postoperative period to employing other agents and techniques including nerve blocks, intra-articular and periarticular injections of local anesthetic agents, NSAIDs, and less commonly, ketamine, tranexamic acid (TXA), sedatives, gabapentin, and corticosteroids. More often, these agents are now used in combination and in synergy with one another as part of a multimodal approach to pain management in ACLR, with the goal of reducing postoperative pain, opioid consumption, and the incidence of delayed hospital discharge. The purpose of this review is to consolidate current literature on various agents involved in the management of postoperative pain following ACLR, including the role of classically used opiate and opioid medications, as well as to describe other drugs currently utilized in practice either individually or in conjunction with other agents as part of a multimodal regimen in pain management in ACLR. Keywords: anterior cruciate ligament reconstruction, ACL, postoperative pain, patient outcomes, multimodal pain management Anterior cruciate ligament tears are one of the most common sports injuries in the United States. 1 Anterior cruciate ligament reconstruction (ACLR) is the gold standard in treatment, with an estimated 130,000 arthroscopic procedures performed annually. 2 Most procedures are carried out on an outpatient basis, and though success rates of ACLR are as high as 95%, pain remains the most common postoperative complication delaying patient discharge, and thereby increasing the costs associated with patient care. 2,3 Compared across other orthopedic sports medicine procedures including rotator cuff repair, meniscal debridement, and labral repair, ACLR has subjectively been ranked as the most painful. 4 Despite the success and relative frequency of ACLR surgery, optimal and widely accepted strategies and regimens for controlling perioperative pain are not well established. 5 Since successful management of postoperative pain is often correlated with improved patient outcomes, developing an effective strategy to provide adequate pain relief is of importance to orthopedic surgeons. 6 Regimens in postoperative pain management after ACLR vary significantly and range from agents used either individually or given in conjunction with other medications. Common agents in current practice include narcotics, non-steroidal anti-inflammatory agents (NSAIDs), and anesthetic agents such as lidocaine or bupivacaine that have nerve blocking and regional anesthetic capabilities. Less commonly used agents include ketamine, tranexamic acid (TXA), sedatives, gabapentinoids, and corticosteroids. 7 While historically, opiates and opioids were the gold standard in postoperative pain control, complications associated with prolonged narcotic use have shifted the paradigm of pain management in orthopedic practice towards a greater focus on optimizing multimodal pain control regimens to reduce the role of narcotics. 8–10 The purpose of this review is to consolidate current literature on various agents involved in the management of postoperative pain following ACLR, including the role of classically used opiate and opioid medications, as well as to describe other drugs currently utilized in practice either individually or in conjunction with other agents as part of a multimodal regimen in pain management after ACLR. Opiates and their synthetic analogs, opioids, were among the most popular pain control modalities used in the acute postoperative period for a variety of orthopedic procedures. Medications in this class are thought to act on the central nervous system as agonists of the Mu receptor. While opioids -Abstract Truncated-